Elevation Oncology logo

Elevation Oncology Share Price Today

(NASDAQ: ELEV)

Elevation Oncology share price is $0.51 & ₹44.40 as on 6 Mar 2025, 2.30 'hrs' IST

$0.51

0.02

(4.89%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Elevation Oncology share price in Dollar and Rupees. Guide to invest in Elevation Oncology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Elevation Oncology, along with analyst recommendations, forecasts, and comprehensive financials.

Elevation Oncology share price movements

  • Today's Low: $0.46
    Today's High: $0.53

    Day's Volatility :12.63%

  • 52 Weeks Low: $0.41
    52 Weeks High: $5.83

    52 Weeks Volatility :92.89%

Elevation Oncology (ELEV) Returns

PeriodElevation Oncology IncIndex (Russel 2000)
3 Months
-13.73%
0.0%
6 Months
-21.52%
0.0%
1 Year
-89.08%
0.0%
3 Years
-83.22%
-11.6%

Elevation Oncology (ELEV) Key Statistics

in dollars & INR

Previous Close
$0.4863
Open
$0.486
Today's High
$0.5299
Today's Low
$0.463
Market Capitalization
$28.7M
Today's Volume
$409.7K
52 Week High
$5.8299
52 Week Low
$0.4146
Revenue TTM
$0.0
EBITDA
$-42.0M
Earnings Per Share (EPS)
$-0.81
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-63.67%

How to invest in Elevation Oncology Stock (ELEV) from India?

It is very easy for Indian residents to invest directly in Elevation Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Elevation Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Elevation Oncology or ELEV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Elevation Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Elevation Oncology shares which would translate to 1.707 fractional shares of Elevation Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Elevation Oncology, in just a few clicks!

Returns in Elevation Oncology (ELEV) for Indian investors in Rupees

The Elevation Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Elevation Oncology investment value today

Current value as on today

₹15,985

Returns

₹84,015

(-84.01%)

Returns from Elevation Oncology Stock

₹89,079 (-89.08%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Elevation Oncology (ELEV)

-43%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Elevation Oncology Stock from India on INDmoney has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Elevation Oncology

  • TANG CAPITAL MANAGEMENT LLC

    8.05%

  • Farallon Capital Management, L.L.C.

    5.97%

  • BlackRock Inc

    5.35%

  • Bvf Inc

    5.02%

  • Aisling Capital Management LP

    4.80%

  • Vanguard Group Inc

    4.41%

Analyst Recommendation on Elevation Oncology

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Elevation Oncology(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Elevation Oncology Stock (ELEV)

What analysts predicted

Upside of 1272.55%

Target:

$7.00

Current:

$0.51

Insights on Elevation Oncology Stock (Ticker Symbol: ELEV)

  • Price Movement

    In the last 1 year, ELEV stock has moved down by -89.1%
  • ELEV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 155.6%
  • ELEV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 135.3%

Elevation Oncology Technicals Summary

Sell

Neutral

Buy

Elevation Oncology is currently in a neutral trading position according to technical analysis indicators.

Elevation Oncology (ELEV) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Elevation Oncology Inc logo
-20.8%
-21.52%
-89.08%
-83.22%
-95.54%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Elevation Oncology Inc logo
NA
NA
NA
-0.87
-0.64
-0.25
NA
1.17
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Elevation Oncology Inc logo
Buy
$28.7M
-95.54%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Elevation Oncology

Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a clinically validated molecular target. Its EO-3021 selectively delivers a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Elevation Oncology, Inc. has a license agreement with CSPC Megalith Biopharmaceutical Co., Ltd. to develop and commercialize EO-3021. The company was formerly known as 14ner Oncology, Inc. and changed its name to Elevation Oncology, Inc. in February 2020. The company was incorporated in 2019 and is based in Boston, Massachusetts.
Organization
Elevation Oncology
Employees
29
CEO
Mr. Joseph J. Ferra Jr.
Industry
Miscellaneous

Management People of Elevation Oncology

NameTitle
Mr. Joseph J. Ferra Jr.
CEO, President & Director
Ms. Valerie Malyvanh Jansen M.D., Ph.D.
Chief Medical Officer
Ms. Tammy Furlong CPA, P.M.P.
CFO & Secretary
Mr. Robert C. Yang
Senior VP & General Counsel
Mr. Ryan Bloomer
Head of Tech Ops
Mr. Biren Shah
Senior Vice President of Business & Corporate Development

Important FAQs about investing in ELEV Stock from India :

What is Elevation Oncology share price today?

Elevation Oncology share price today stands at $0.51, Open: $0.49 ; Previous Close: $0.49 ; High: $0.53 ; Low: $0.46 ; 52 Week High: $5.83 ; 52 Week Low: $0.41.

The stock opens at $0.49, after a previous close of $0.49. The stock reached a daily high of $0.53 and a low of $0.46, with a 52-week high of $5.83 and a 52-week low of $0.41.

Can Indians buy Elevation Oncology shares?

Yes, Indians can invest in the Elevation Oncology (ELEV) from India.

With INDmoney, you can buy Elevation Oncology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Elevation Oncology at zero transaction cost.

How can I buy Elevation Oncology shares from India?

It is very easy to buy Elevation Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Elevation Oncology (ELEV) be purchased?

Yes, you can buy fractional shares of Elevation Oncology with INDmoney app.

What are the documents required to start investing in Elevation Oncology stocks?

To start investing in Elevation Oncology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Elevation Oncology Stock (ELEV)?

Today’s highest price of Elevation Oncology (ELEV) is $0.53.

Today’s lowest price of Elevation Oncology (ELEV) is $0.46.

What is today's market capitalisation of Elevation Oncology?

Today's market capitalisation of Elevation Oncology ELEV is 28.7M

What is the 52 Week High and Low Range of Elevation Oncology Stock (ELEV)?

  • 52 Week High

    $5.83

  • 52 Week Low

    $0.41

What are the historical returns of Elevation Oncology (ELEV)?

  • 1 Month Returns

    -20.8%

  • 3 Months Returns

    -21.52%

  • 1 Year Returns

    -89.08%

  • 5 Years Returns

    -95.54%

Who is the Chief Executive Officer (CEO) of Elevation Oncology ?

Mr. Joseph J. Ferra Jr. is the current Chief Executive Officer (CEO) of Elevation Oncology.